Akcea Therapeutics Reports Financial Results And Highlights For Second Quarter 2017

Published: Aug 08, 2017

CAMBRIDGE, Mass., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders, today reported financial results for the second quarter ended June 30, 2017, and provided an update on upcoming events and key achievements.

Back to news